MedPath

Polymyxin B Sulfate and Trimethoprim

(Sterile)

Approved
Approval ID

000775ae-38dc-40ea-b96f-a0baf5d03511

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 12, 2023

Manufacturers
FDA

A-S Medication Solutions

DUNS: 830016429

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Polymyxin B Sulfate and Trimethoprim Sulfate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code50090-2398
Application NumberANDA064120
Product Classification
M
Marketing Category
C73584
G
Generic Name
Polymyxin B Sulfate and Trimethoprim Sulfate
Product Specifications
Route of AdministrationOPHTHALMIC
Effective DateJune 1, 2023
FDA Product Classification

INGREDIENTS (7)

POLYMYXIN B SULFATEActive
Quantity: 10000 [USP'U] in 1 mL
Code: 19371312D4
Classification: ACTIM
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
BENZALKONIUM CHLORIDEInactive
Code: F5UM2KM3W7
Classification: IACT
SULFURIC ACIDInactive
Code: O40UQP6WCF
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
TRIMETHOPRIM SULFATEActive
Quantity: 1 mg in 1 mL
Code: E377MF8EQ8
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.